Evidence map›Paper›PMID 38876735›Full record

ArticleThe Lancet. Neurology2024

Concerns with the new biological research criteria for synucleinopathy.

Bradley F Boeve, Albert A Davis, Yo-El Ju, Kejal Kantarci, Wolfgang Singer, Aleks Videnovic, NAPS co-investigators

Abstract readLetterComment
In one paragraph

Article in The Lancet. Neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks?Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  2. Review
  3. Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  4. Article
  5. Initial biological classification of Lewy body diseases: No consensus on terminology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Bradley F BoeveDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: bboeve@mayo.edu.
Albert A DavisDepartment of Neurology, Washington University, St. Louis, MO, USA.
Yo-El JuDepartment of Neurology, Washington University, St. Louis, MO, USA.
Kejal KantarciDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Wolfgang SingerDepartment of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Aleks VidenovicDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
NAPS co-investigators

Funding

Project: Predicting PhenoconversionU19AG071754 · NIA · WASHINGTON UNIVERSITY · PI Ronald Postuma · 2021 to 2026
$41.2M
Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Allison Lindauer · 2020 to 2026
$28.6M
Longitudinal Imaging Biomarkers of Prodromal DLBU01NS100620 · NINDS · MAYO CLINIC ROCHESTER · PI Bradley F Boeve, KEJAL KANTARCI · 2017 to 2026
$19.2M
Neuroprotective Treatment Trial Planning in REM Sleep Behavior DisorderR34AG056639 · NIA · WASHINGTON UNIVERSITY · PI BOEVE, BRADLEY F, JU, YO-EL S · 2018 to 2019
$1.2M
Biomarkers of disease severity and progression in Parkinson'sIK2CX002539 · VA · PORTLAND VA MEDICAL CENTER · PI Lee Neilson · 2023 to 2026
–
CSRD VA IK2 CX002539NIA NIH HHS P30 AG066518NIA NIH HHS R34 AG056639NIA NIH HHS U19 AG071754NINDS NIH HHS U01 NS100620
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

SynucleinopathiesBiomedical ResearchHumans

Identifiers

PMID38876735
PMCPMC12291176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.